Eli Lilly has paused its obesity awareness campaign in India after regulators warned it may violate drug advertising rules, raising compliance concerns. For the full story, visit the source.
Health
India drugs regulator flags Eli Lilly obesity ads, campaign put on holdEli Lilly
Eli Lilly has paused its obesity awareness campaign in India after regulators warned it may violate drug advertising rules, raising compliance concerns.
By Reuters· BusinessLine· 5 months ago· 2 min read
This summary is sourced from BusinessLine. Read the full article at:BusinessLine